5-Hydroxyindoleacetic acid (5-HIAA) and cortisol excretion as predictors of chemotherapy-induced emesis

British Journal of Cancer

Volumn 74, Issue 7, 1996, Pages 1137-1140

  Du Bois, A ^a,c   Vach, W ^b   Wechsel, U ^b   Holy, R ^b   Schaefer, W ^b  

^a St Vincentius Hospital   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c Frauenkl St Vincentius K   (Germany)

Author keywords

5 hydroxyindoleacelic acid (5 HIAA); Carboplatin; Chemotherapy; Cortisol; Emesis; Vomiting

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; CARBOPLATIN; CYCLOPHOSPHAMIDE; CYTOSTATIC AGENT; HYDROCORTISONE; IFOSFAMIDE; ONDANSETRON;

ADULT; ARTICLE; CORRELATION FUNCTION; FEMALE; HUMAN; HYDROCORTISONE URINE LEVEL; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; NAUSEA; ORAL DRUG ADMINISTRATION; OVARY CANCER; PREDICTION; PRIORITY JOURNAL; URINARY EXCRETION; UTERINE CERVIX CANCER; VOMITING;

EID: 0029764510     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.503     Document Type: Article

References (18)

1. 3 antagonists. King FD, Jones BJ, and Sanger GJ (eds). pp.255 317. CRC Press: Boca Raton, USA.
2. BECK TM, CIOCIOLA AA, JONES SE, HARVEY WH, TCHEKMEDYIAN NS, CHANG A, GALONI D, HART NE AND THE ONDANSETRON STUDY GROUP. (1993). Efficacy of oral ondansetron in the prevention of emesis in outpatients receiving cyclophosphamide-based chemotherapy. Ann. Intern. Med., 118, 407 - 413.
3. COATES A, ABRAHAM S, KAYE SB, SOWERBUTTS T, FREWIN C, FOX RM AND TATTERSALL MHN. (1983). On the receiving end patient perception of the side-effects of cancer chemotherapy. Eur. J. Cancer Clin. Oncol., 19, 203 208.
4. CUBEDDU LX, HOFFMANN IS, FUENMAYOR NT AND FINN AI. (1990). Efficacy of ondansetron (GR 38032F) and the role of serotonin in cisplatin-induced nausea and vomiting. N. Engl. J. Med., 322, 816 - 816.
5. CUBEDDU LX, HOFFMANN IS, FUENMAYER NT AND MALAVE JJ. (1992). Changes in serotonin metabolism in cancer patients: its relationship to nausea and vomiting induced by chemotherapeutic drugs. Br. J. Cancer, 66, 198 203.
6. DU BOIS A, SIEBERT C AND KRIESINGER-SCHRÖDER H. (1995). Cisplatin-induced alterations of serotonin metabolism in patients with and without emesis. Oncol. Rep., 2, 839 842.
7. FREDRICKSON M, HURSTI T, FÜRST CJ, STEINECK, G., BÖRJESSON S, WIKBLOM M AND PETERSON C. (1992). Nausea in cancer chemotherapy is inversely related to urinary cortisol excretion. Br. J. Cancer, 65, 779 780.
8. FREDRICKSON M, HURSTI TJ, STEINECK G, FÜRST CJ, BOERJESSON S AND PETERSON C. (1994). Delayed chemotherapy-induced emesis is augmented by high levels of endogenous noradrenaline. Br. J. Cancer, 70, 642 645.
9. GRALLA RJ, ITRI LM, PISKO SE, SQUILLANTE AE, KELSEN DP, BRAUN DW, BORDIN LA, BRAUN TJ AND YOUNG CW. (1981). Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting. N. Engl. J. Med., 305, 905 909.
10. HURSTI TJ, FREDRICKSON M, STEINECK G, BÖRJESSON S, FÜRST CJ AND PETERSON C. (1993). Endogenous cortisol exerts antiemetic effect similar to that of exogenous corticosteroids. Br. J. Cancer, 68, 1731 1734.
11. ITALIAN GROUP FOR ANTIEMETIC RESEARCH. (1995). Dexamethasone, granisetron, or both for the prevention of nausea and vomiting during chemotherapy for cancer. N. Eng. J. Med., 322, 1 5.
12. LIVERA P, TROJANO M AND SIMONE I. (1985). Acute changes in blood CSF barrier permselectivity to serum proteins after intrathecal methotrexate and CNS irradiation. J. Neurol., 231, 336 339.
13. MARTIN M, DIAZ-RUBIO E, SANCHEZ A, ALMENAREZ J AND LOPHZ-VEGA JM. (1990). The natural course of emesis after carboplatin treatment. Acta Oncologica, 29, 593 - 597.
14. MINER WD, SANGER GJ AND TURNER DH. (1987). Evidence that 5-hydroxytryptamine 3 receptors mediate cytotoxic drug and radiation-evoked emesis. Br. J. Cancer. 56, 159 162.
15. MUNCK A, GUYRE PM AND HOLBROOK NJ. (1984). Physiological functions of glucocorticosteroids in stress and their relation to pharmacological actions. Endocrine Rev., 5, 25 - 44.
16. ROILA F, TONATO M, COGNETTI F, CORTESI E, FAVALLI G, MARANGOLO M, AMADORI D, BELLA MA, GRAMAZIO V, DONATI D, BALLATORI E AND DEL FAVERO A. (1991). Prevention of cisplatin-induced emesis: a double-blind multi-center randomized crossover study comparing ondansetron and ondansetron plus dexamethasone. J. Clin. Oncol., 9, 675 - 678.
17. SCHWÖRER H, RACKE K AND KILBINGER H. (1991). Cisplatin increases the release of 5-hydroxytryptamine (5-HT) from the isolated vasculary perfused small intestine of the guinea-pig: involvement of the 5-HT3 receptors. Naunyn Schmiedeberg's Arch. Pharmacol., 344, 143 149.
18. YOUNG S.N. (1981). Mechanisms of decline in rat brain 5-hydroxytryptamine after induction of liver tryptophan pyrrolase by hydrocortison: roles for tryptophan catabolism and kynurenine synthesis. Br. J. Pharmacol., 74, 695.